HIV Vaccine Trials Network (HVTN), Vaccine and Infectious Disease Division, Fred Hutch
Research interests include the development of HIV vaccines for adults and children. Part of the core leadership team on network strategic planning and implementation, as the HVTN Chief of Staff. Primary research focus is in the HVTN’s phase 1 experimental medicine program for induction of broadly neutralizing antibodies against sites of vulnerability on the HIV envelope protein.
Harvard University, 2012, MPH
University of Washington, 1999, MD
Neutralizing vaccines for HIV and other viruses
Non-neutralizing and T-cell approaches to HIV vaccine development
Immune responses to vaccines in adults and infants
Vaccines for TB, malaria, and other diseases of global concern